Soleno Therapeutics (SLNO) Intangibles (2015 - 2026)
Soleno Therapeutics (SLNO) reported Intangibles of $4.4 million for Q1 2026, down 30.77% year-over-year from $6.3 million in Q1 2025, and down 10.02% on a QoQ basis from $4.9 million in Q4 2025.
Soleno Therapeutics (SLNO) has 12 years of Intangibles data on file, last reported at $4.4 million in Q1 2026.
- Quarterly Intangibles fell 30.77% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 30.77% YoY) and the FY2025 annual result came in at $4.9 million, down 28.57% from the prior year.
- Intangibles slipped to $4.4 million in Q1 2026 per SLNO's latest filing, from $4.9 million in the prior quarter.
- Across five years, Intangibles topped out at $12.2 million in Q1 2022 and bottomed at $4.4 million in Q1 2026.
- The 5-year median for Intangibles is $8.3 million (2024), against an average of $8.3 million.
- The widest annual swing landed in 2022, when Intangibles dropped 13.79%; it then tumbled 30.77% in 2026.
- Tracing SLNO's Intangibles over 5 years: stood at $10.7 million in 2022, then retreated by 18.18% to $8.7 million in 2023, then decreased by 22.22% to $6.8 million in 2024, then slipped by 28.57% to $4.9 million in 2025, then dropped by 10.02% to $4.4 million in 2026.
- Per Business Quant, the three latest SLNO Intangibles figures stand at $4.4 million (Q1 2026), $4.9 million (Q4 2025), and $5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 4.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.37 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Sep 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 6.32 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Sep 30, 2024 | 7.29 Mn |
| Jun 30, 2024 | 7.78 Mn |
| Mar 31, 2024 | 8.26 Mn |
| Dec 31, 2023 | 8.75 Mn |
| Sep 30, 2023 | 9.24 Mn |
| Jun 30, 2023 | 9.72 Mn |
| Mar 31, 2023 | 10.21 Mn |
| Dec 31, 2022 | 10.69 Mn |
| Sep 30, 2022 | 11.18 Mn |
| Jun 30, 2022 | 11.67 Mn |
| Mar 31, 2022 | 12.15 Mn |
| Dec 31, 2021 | 12.64 Mn |
| Sep 30, 2021 | 13.12 Mn |
| Jun 30, 2021 | 13.61 Mn |
| Mar 31, 2021 | 14.10 Mn |
| Dec 31, 2020 | 14.58 Mn |
| Sep 30, 2020 | 15.07 Mn |
| Jun 30, 2020 | 15.55 Mn |
| Mar 31, 2020 | 16.04 Mn |
| Dec 31, 2019 | 16.53 Mn |
| Sep 30, 2019 | 17.01 Mn |
| Jun 30, 2019 | 17.50 Mn |
| Mar 31, 2019 | 17.98 Mn |
| Dec 31, 2018 | 18.47 Mn |
| Sep 30, 2018 | 18.96 Mn |
| Jun 30, 2018 | 19.44 Mn |
| Mar 31, 2018 | 19.93 Mn |
| Dec 31, 2017 | 20.41 Mn |
| Sep 30, 2017 | 19.35 Mn |
| Jun 30, 2017 | 19.88 Mn |
| Mar 31, 2017 | 21.13 Mn |
| Sep 30, 2016 | 842,000.00 |
| Jun 30, 2016 | 867,000.00 |
| Mar 31, 2016 | 892,000.00 |
| Dec 31, 2015 | 76,340.00 |
| Sep 30, 2015 | 946,000.00 |
| Jun 30, 2015 | 562,000.00 |